{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:57:00Z","timestamp":1792231020626,"version":"4.4.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Osteonecrosis of the femoral head (ONFH) is a cause of hip pain and early joint arthrosis in the young patient. Nonarthroplasty interventions aim to decompress vascular congestion in the femoral head and stimulate new bone growth to prevent progression and collapse. Therefore, the purpose of this study is to evaluate the available evidence on the effect of adjuvant bone marrow stem cells (BMSCs) for early stage ONFH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We performed a systematic review of the MEDLINE, PubMed, Embase, and Cochrane databases in search of published reports comparing the core decompression (CD) with\/without adjuvant BMSCs for ONFH. The cohort was divided into two groups: (1) CD with BMSCs (intervention) and (2) CD alone (control subject). The various outcome parameters including hip pain and function, progression of ONFH, rate of revision surgeries, and complications were analyzed. Data were extracted and aggregated for meta-analysis. Cases with staging beyond Ficat II, UPENN II, or ARCO II were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the published reports, 16 met our inclusion criteria with an aggregated 583 hips in the intervention and 468 hips in the control subject groups, respectively. Addition of bone marrow cells to CD resulted in lower hip pain score (VAS) (MD = \u221210.88, 95% CI = \u221216.84 to \u22124.92,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003) and higher HHS score (MD = 5.59, 95% CI = 1.13 to 10.04,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01) compared with CD alone at the 24-month follow-up. For rates of progression to higher stages, 138 progressed in the intervention group compared with 202 in the control subject group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0002). Finally, subsequent patients who required total hip arthroplasty surgery were lower in the intervention group (22.5% versus 42.3%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Despite heterogeneous and poor data, there is evidence that addition of bone marrow cells to CD appears to result in better clinical outcomes and lower rates of disease progression compared with cored decompression alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Therapeutic Level III<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-19-00816","type":"journal-article","created":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T22:02:38Z","timestamp":1583100158000},"page":"973-979","source":"Crossref","is-referenced-by-count":26,"title":["Addition of Bone Marrow Stem Cells Therapy Achieves Better Clinical Outcomes and Lower Rates of Disease Progression Compared With Core Decompression Alone for Early Stage Osteonecrosis of the Femoral Head: A Systematic Review and Meta-Analysis"],"prefix":"10.5435","volume":"28","author":[{"given":"Chaofan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zida","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwo-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"R1-20230714","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2106\/JBJS.N.01157","article-title":"Does Zoledronate prevent femoral head collapse from osteonecrosis?","volume":"97","author":"Lee","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"R2-20230714","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11999-013-3220-3","article-title":"Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the nationwide inpatient sample","author":"Johnson","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"R3-20230714","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2106\/00004623-199809000-00004","article-title":"Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis","volume":"80","author":"Scully","year":"1998","journal-title":"J Bone Joint Surg Am"},{"key":"R4-20230714","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s002640050335","article-title":"Core decompression in osteonecrosis of the femoral head: Risk-factor-dependent outcome evaluation using survivorship analysis","volume":"23","author":"Simank","year":"1999","journal-title":"Int Orthop"},{"key":"R5-20230714","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s002640000186","article-title":"Failure after core decompression in osteonecrosis of the femoral head","volume":"24","author":"Yoon","year":"2001","journal-title":"Int Orthop"},{"key":"R6-20230714","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00003086-200105000-00009","article-title":"Core decompression with bone grafting for osteonecrosis of the femoral head","volume":"386","author":"Steinberg","year":"2001","journal-title":"Clin Orthop Relat Res"},{"key":"R7-20230714","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4055\/cios.2016.8.1.1","article-title":"Stem cell therapy for the treatment of hip Osteonecrosis\u202f: A 30-year review of progress","volume":"8","author":"Hernigou","year":"2016","journal-title":"Clin Orthop Surg"},{"key":"R8-20230714","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11999.0000000000000033","article-title":"Stem cells combined with platelet-rich plasma E ff ectively treat corticosteroid-induced osteonecrosis of the hip: A prospective study","volume":"476","author":"Houdek","year":"2018","journal-title":"Clin Orthop Relat Res"},{"key":"R9-20230714","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12178-015-9281-z","article-title":"Osteonecrosis of the femoral head\u202f: Treatment with ancillary growth factors","volume":"8","author":"Houdek","year":"2015","journal-title":"Curr Rev Musculoskelet Med"},{"key":"R10-20230714","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1177\/0300060514546940","article-title":"Complete resolution of avascular necrosis of the human femoral head treated with adipose tissue-derived stem cells and platelet-rich plasma","volume":"42","author":"Pak","year":"2014","journal-title":"J Intern Med Res"},{"key":"R11-20230714","doi-asserted-by":"crossref","first-page":"e100424","DOI":"10.1371\/journal.pone.0100424","article-title":"Recombinant human bone morphogenetic protein-2 in debridement and impacted bone graft for the treatment of femoral head osteonecrosis","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"R13-20230714","first-page":"5","article-title":"Core decompression and autologous bone marrow concentrate for treatment of femoral head osteonecrosis: A randomized prospective study","volume":"8","author":"Pepke","year":"2016","journal-title":"Orthop Rev (Pavia)"},{"key":"R14-20230714","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arth.2015.06.022","article-title":"Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral Head\u202f: A comparative study","volume":"30","author":"Tabatabaee","year":"2015","journal-title":"J Arthroplasty"},{"key":"R15-20230714","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.arth.2011.08.008","article-title":"Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis A randomized control study","volume":"27","author":"Sen","year":"2012","journal-title":"J Arthroplasty"},{"key":"R16-20230714","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bone.2011.11.002","article-title":"Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells","volume":"50","author":"Zhao","year":"2012","journal-title":"Bone"},{"key":"R17-20230714","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00264-018-3941-8","article-title":"Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: A thirty year follow-up prospective randomized study of one hundred and twenty five adult patients","volume":"42","author":"Hernigou","year":"2018","journal-title":"Int Orthop"},{"key":"R18-20230714","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/scrt505","article-title":"Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head\u202f: A prospective, double-blinded, randomized, controlled study","volume":"5","author":"Ma","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"R19-20230714","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/jbmr.2390","article-title":"Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: A randomized controlled clinical trial","volume":"30","author":"Mao","year":"2015","journal-title":"J Bone Miner Res"},{"key":"R20-20230714","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2106\/00004623-200406000-00006","article-title":"Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study","volume":"86","author":"Gangji","year":"2004","journal-title":"J Bone Joint Surg Am"},{"key":"R21-20230714","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bone.2011.07.032","article-title":"Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study","volume":"49","author":"Gangji","year":"2011","journal-title":"Bone"},{"key":"R22-20230714","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13287-018-1030-y","article-title":"Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: A matched pair control study with simple core decompression","volume":"9","author":"Kang","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"R23-20230714","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1302\/0301-620X.92B3.22483","article-title":"Bone-marrow-derived mononuclear cells with a porous hydroxyapatite scaffold for the treatment of osteonecrosis of the femoral head: A preliminary study","volume":"92","author":"Yamasaki","year":"2010","journal-title":"J Bone Joint Surg Br"},{"key":"R24-20230714","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00402-012-1623-3","article-title":"Core decompression and implantation of bone marrow mononuclear cells with porous hydroxylapatite composite filler for the treatment of osteonecrosis of the femoral head","volume":"133","author":"Liu","year":"2013","journal-title":"Arch Orthop Trauma Surg"},{"key":"R25-20230714","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1038\/emm.2013.128","article-title":"Stem cell implantation for osteonecrosis of the femoral head","volume":"45","author":"Lim","year":"2013","journal-title":"Exp Mol Med"},{"key":"R26-20230714","first-page":"111","article-title":"Bone marrow aspirate concentrate in combination with intravenous iloprost increases bone healing in patients with avascular necrosis of the femoral head: A matched pair analysis","volume":"8","author":"Pilge","year":"2016","journal-title":"Orthop Rev (Pavia)"},{"key":"R27-20230714","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/BCO.0000000000000218","article-title":"Autologous mesenchymal stem cell implantation in the management of osteonecrosis of the femoral head","volume":"26","author":"Yan","year":"2015","journal-title":"Curr Orthop Pract"},{"key":"R28-20230714","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5301\/hipint.5000366","article-title":"Mid-term comparative outcomes of autologous bone-marrow concentration to treat osteonecrosis of the femoral head in standard practice","volume":"26","author":"Cruz-Pardos","year":"2016","journal-title":"HIP Int"},{"key":"R29-20230714","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijsu.2019.06.016","article-title":"Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis","volume":"69","author":"Wang","year":"2019","journal-title":"Int J Surg"},{"key":"R30-20230714","first-page":"5024","article-title":"Comparison of bone marrow mesenchymal stem cells and core decompression in treatment of osteonecrosis of the femoral head: A meta-analysis","volume":"7","author":"Li","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R31-20230714","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00003086-200212000-00003","article-title":"Treatment of osteonecrosis with autologous bone marrow grafting","volume":"405","author":"Hernigou","year":"2002","journal-title":"Clin Orthop Relat Res"},{"key":"R32-20230714","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00264-018-3787-0","article-title":"Regenerative therapies increase survivorship of avascular necrosis of the femoral head: A systematic review and meta-analysis","volume":"42","author":"Andriolo","year":"2018","journal-title":"Int Orthop"},{"key":"R33-20230714","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.arth.2016.12.049","article-title":"Evidence for the use of cell-based therapy for the treatment of osteonecrosis of the femoral Head: A systematic review of the literature","volume":"32","author":"Piuzzi","year":"2017","journal-title":"J Arthroplasty"},{"key":"R34-20230714","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5301\/hipint.5000552","article-title":"THA conversion rate comparing decompression alone, with autologous bone graft or stem cells in osteonecrosis","volume":"28","author":"Nally","year":"2018","journal-title":"Hip Int"},{"key":"R35-20230714","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00264-017-3650-8","article-title":"Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: A randomized controlled double-blind trial","volume":"42","author":"Hauzeur","year":"2018","journal-title":"Int Orthop"},{"key":"R37-20230714","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2106\/JBJS.19.01268","article-title":"JBJS endorses concerns regarding speculative commercial cell-banking services","volume":"102","author":"Bauer","year":"2020","journal-title":"J Bone Joint Surg Am"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-19-00816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:40:00Z","timestamp":1787668800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-19-00816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":35,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-19-00816","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]}}}